Landsberg Bennett & Dubbaneh’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$651K Hold
1,732
0.08% 156
2021
Q2
$661K Hold
1,732
0.09% 156
2021
Q1
$613K Hold
1,732
0.09% 154
2020
Q4
$556K Hold
1,732
0.09% 139
2020
Q3
$450K Sell
1,732
-182
-10% -$49K 0.08% 147
2020
Q2
$496K Buy
1,914
+157
+9% +$41.9K 0.1% 144
2020
Q1
$371K Sell
1,757
-1,594
-48% -$434K 0.1% 127
2019
Q4
$1.02M Buy
3,351
+1,619
+93% +$446K 0.24% 108
2019
Q3
$412K Hold
1,732
0.11% 154
2019
Q2
$490K Hold
1,732
0.13% 152
2019
Q1
$498K Buy
+1,732
New +$501K 0.12% 149

Other funds holding ELV

Landsberg Bennett & Dubbaneh's ELV Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh held its Elevance Health (ELV) position steady in Q3 2021 at 1,732 shares worth $651K. The position accounts for 0.08% of the portfolio, ranked #156.

Landsberg Bennett & Dubbaneh first reported a position in ELV in Q1 2019 and has held it in 11 quarters since. The position peaked at $1.02M in Q4 2019. 1,215 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Landsberg Bennett & Dubbaneh held 1,732 shares of Elevance Health worth $651K as of Q3 2021.
  • Landsberg Bennett & Dubbaneh left its Elevance Health share count unchanged in Q3 2021.
  • Elevance Health made up 0.08% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #156 holding.
  • Landsberg Bennett & Dubbaneh first reported a position in Elevance Health in Q1 2019 and has held it in 11 quarters since.
  • Landsberg Bennett & Dubbaneh's Elevance Health position peaked at $1.02M in Q4 2019.
  • 1,215 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.